FISCLO: Multiparametric MRI for Assessment of Changes of Renal Hemodynamics After Fistula Closure in Kidney Transplant Patients

Sponsor
University of Zurich (Other)
Overall Status
Recruiting
CT.gov ID
NCT05015231
Collaborator
(none)
30
1
77
0.4

Study Details

Study Description

Brief Summary

Assessment of changes of renal hemodynamics by multiparametric MRI after closure of AVF access.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Echocardiography and MRI

Study Design

Study Type:
Observational
Anticipated Enrollment :
30 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Multiparametric MRI for Assessment of Changes of Renal Hemodynamics After Fistula Closure in Kidney Transplant Patients: a Pilot Study
Actual Study Start Date :
Aug 1, 2021
Anticipated Primary Completion Date :
Dec 31, 2027
Anticipated Study Completion Date :
Dec 31, 2027

Outcome Measures

Primary Outcome Measures

  1. Assessment of changes in renal hemodynamics by multiparametric MRI after closure of AVF access [evaluation of short term changes within 2 weeks after fistula closure and longterm changes 6 months after fistula closure]

    Assessing changes in renal perfusion

  2. Assessment of changes in renal hemodynamics by multiparametric MRI after closure of AVF access [evaluation of short term changes within 2 weeks after fistula closure and longterm changes 6 months after fistula closure]

    Assessing changes in renal oxygenation

Secondary Outcome Measures

  1. Correlation between AVF access flow and changes as assessed during pneumatic fistula compression with changes in renal hemodynamics after fistula closure [evaluation of short term changes within 2 weeks after fistula closure and longterm changes 6 months after fistula closure]

    Correlation between AVF access flow and changes as assessed during pneumatic fistula compression with changes in renal hemodynamics after fistula closure

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Written informed consent

  • Age > 18 years

  • Patients wishing to close the fistula and planned for surgical fistula closure

  • eGFR CKD EPI ≥ 45 ml/min/1.73m2 at one year post transplantation

  • Stable eGFR within the past 6 months

  • Controlled blood pressure

Exclusion Criteria:
  • Kidney Transplantation < 12 months before fistula closure

  • Proteinuria > 500mg/d

  • Presence of donor specific antibodies

  • Rejection within the past 6 months

  • BK virus replication within the past 3 months

  • Cardiac pacemaker, which is not compatible with MRI

  • Claustrophobia

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Zurich Zurich Switzerland 8091

Sponsors and Collaborators

  • University of Zurich

Investigators

  • Principal Investigator: Thomas Müller, Professor, University Hospital Zurich, Nephrology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Zurich
ClinicalTrials.gov Identifier:
NCT05015231
Other Study ID Numbers:
  • 2021-00474
First Posted:
Aug 20, 2021
Last Update Posted:
Aug 20, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 20, 2021